Latest News

STAT Plus: Seres announces positive late-stage results for its microbe-based drug

Four years after a devastating clinical trial failure, Seres Therapeutics seems to have found success. The company announced positive results Monday for its late-stage clinical trial of a microbe-based treatment for C. difficile.

About 11% of patients who got Seres’ drug, a pill made with bacteria, still had a C. difficile recurrence; about 41% of people who did not get the drug saw their infection recur.

Continue to STAT Plus to read the full story…

Source link

Related posts

Medical News Today: What is explosive diarrhea?


How Video Games Can Boost Your Mental And Physical Health


Gene-editing technique CRISPR trialed for first time as cancer treatment


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World